Witnessing the stock’s movement on the chart, on Wednesday, Editas Medicine Inc (NASDAQ: EDIT) set off with pace as it heaved 6.56% to $2.6, before settling in for the price of $2.44 at the close. Taking a more long-term approach, EDIT posted a 52-week range of $0.91-$4.54.
The Healthcare sector firm’s twelve-monthly sales growth has been -1.48% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -1.48%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 31.20%. This publicly-traded company’s shares outstanding now amounts to $97.62 million, simultaneously with a float of $97.07 million. The organization now has a market capitalization sitting at $253.81 million. At the time of writing, stock’s 50-day Moving Average stood at $3.05, while the 200-day Moving Average is $2.35.
Editas Medicine Inc (EDIT) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Editas Medicine Inc’s current insider ownership accounts for 0.57%, in contrast to 45.44% institutional ownership. According to the most recent insider trade that took place on Dec 03 ’25, this organization’s EVP, CHIEF SCIENTIFIC OFFICER sold 713 shares at the rate of 2.15, making the entire transaction reach 1,535 in total value, affecting insider ownership by 68,777. Preceding that transaction, on Dec 03 ’25, Company’s CEO sold 5,603 for 2.15, making the whole transaction’s value amount to 12,064. This particular insider is now the holder of 269,087 in total.
Editas Medicine Inc (EDIT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year. Editas Medicine Inc’s EPS increase for this current 12-month fiscal period is 31.20% and is forecasted to reach -1.09 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 28.82% through the next 5 years, which can be compared against the -1.48% growth it accomplished over the previous five years trading on the market.
Editas Medicine Inc (NASDAQ: EDIT) Trading Performance Indicators
Let’s observe the current performance indicators for Editas Medicine Inc (EDIT). It’s Quick Ratio in the last reported quarter now stands at 2.86. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.47.
In the same vein, EDIT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.38, a figure that is expected to reach -0.23 in the next quarter, and analysts are predicting that it will be -1.09 at the market close of one year from today.
Technical Analysis of Editas Medicine Inc (EDIT)
Going through the that latest performance of [Editas Medicine Inc, EDIT]. Its last 5-days volume of 1.54 million was inferior to the volume of 2.71 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 83.08% While, its Average True Range was 58.45.
Raw Stochastic average of Editas Medicine Inc (EDIT) in the period of the previous 100 days is set at 21.48%, which indicates a major fall in contrast to 79.69% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.17 that was lower than 0.24 volatility it exhibited in the past 100-days period.
